Top

World Journal of Urology

Published in:

01-02-2015 | Topic Paper

Metabolic evaluation of urinary lithiasis: what urologists should know and do

Authors: Julien Letendre, Jonathan Cloutier, Luca Villa, Luc Valiquette

Published in: World Journal of Urology | Issue 2/2015

Abstract

Introduction

Urolithiasis is a complex medical entity and regroups several different types of stones, each caused by a multitude of dietary imbalances or metabolic anomalies. In order to better assess the stone-forming patient, urologists should be competent in performing a thorough metabolic work-up.

Materials and methods

We reviewed the litterature in order to provide an appropriate overview of the various components of the metabolic evaluation, including stone analysis, biochemistry tests, and urine collection.

Conclusion

Performing a metabolic evaluation allows precise intervention in order to treat and mainly prevent stone disease.

Paterson R, Fernandez A, Razvi H, Sutton R (2010) Evaluation and medical management of the kidney stone patient. Can Urol Assoc J 4(6):375–379PubMedCentralPubMedCrossRef

Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM, White JR, American Urological A (2014) Medical management of kidney stones: AUA guideline. J Urol 192(2):316–324. doi:10.1016/j.juro.2014.05.006 PubMedCrossRef

Türk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, Seitz C (2014) The updated EAU guidelines on urolithiasis. EAU Guidelines, edition presented at the 29th EAU annual congress, Stockholm

Pearle MS, Roehrborn CG, Pak CY (1999) Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13(9):679–685PubMedCrossRef

Borghi L, Meschi T, Guerra A, Novarini A (1993) Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22(Suppl 6):S78–S86PubMedCrossRef

Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158(6):2069–2073PubMedCrossRef

Ettinger B, Citron JT, Livermore B, Dolman LI (1988) Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139(4):679–684PubMed

Ettinger B, Tang A, Citron JT, Livermore B, Williams T (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315(22):1386–1389. doi:10.1056/NEJM198611273152204 PubMedCrossRef

Laerum E, Larsen S (1984) Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand 215(4):383–389PubMedCrossRef

10.

Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150(6):1761–1764PubMed

11.

Hofbauer J, Hobarth K, Szabo N, Marberger M (1994) Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis–a prospective randomized study. Br J Urol 73(4):362–365PubMedCrossRef

12.

Scholz D, Schwille PO, Sigel A (1982) Double-blind study with thiazide in recurrent calcium lithiasis. J Urol 128(5):903–907PubMed

13.

Pak CY, Sakhaee K, Fuller C (1986) Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int 30(3):422–428PubMedCrossRef

14.

Pak CY, Odvina CV, Pearle MS, Sakhaee K, Peterson RD, Poindexter JR, Brinkley LJ (2005) Effect of dietary modification on urinary stone risk factors. Kidney Int 68(5):2264–2273. doi:10.1111/j.1523-1755.2005.00685.x PubMedCrossRef

15.

Lotan Y, Pearle MS (2011) Cost-effectiveness of primary prevention strategies for nephrolithiasis. J Urol 186(2):550–555. doi:10.1016/j.juro.2011.03.133 PubMedCrossRef

16.

Eisner BH, Sheth S, Dretler SP, Herrick B, Pais VM Jr (2012) Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers. Urology 80(4):776–779. doi:10.1016/j.urology.2012.06.034 PubMedCrossRef

17.

Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America P (2012) Prevalence of kidney stones in the United States. Eur Urol 62(1):160–165. doi:10.1016/j.eururo.2012.03.052 PubMedCentralPubMedCrossRef

18.

Trinchieri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 162(1):27–30. doi:10.1097/00005392-199907000-00007 PubMedCrossRef

19.

Worcester EM, Coe FL (2008) New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol 28(2):120–132. doi:10.1016/j.semnephrol.2008.01.005 PubMedCentralPubMedCrossRef

20.

Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol 15(12):3225–3232. doi:10.1097/01.ASN.0000146012.44570.20 PubMedCrossRef

21.

Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155(3):839–843PubMedCrossRef

22.

Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ (1996) Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 143(3):240–247PubMedCrossRef

23.

Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346(2):77–84. doi:10.1056/NEJMoa010369 PubMedCrossRef

24.

Smith-Bindman R, Aubin C, Bailitz J, Bengiamin RN, Camargo CA Jr, Corbo J, Dean AJ, Goldstein RB, Griffey RT, Jay GD, Kang TL, Kriesel DR, Ma OJ, Mallin M, Manson W, Melnikow J, Miglioretti DL, Miller SK, Mills LD, Miner JR, Moghadassi M, Noble VE, Press GM, Stoller ML, Valencia VE, Wang J, Wang RC, Cummings SR (2014) Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med 371(12):1100–1110. doi:10.1056/NEJMoa1404446 PubMedCrossRef

25.

McPhail EF, Gettman MT, Patterson DE, Rangel LJ, Krambeck AE (2012) Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features. Urology 79(2):277–281. doi:10.1016/j.urology.2011.07.1414 PubMedCrossRef

26.

Gambaro G, Fabris A, Puliatta D, Lupo A (2006) Lithiasis in cystic kidney disease and malformations of the urinary tract. Urol Res 34(2):102–107. doi:10.1007/s00240-005-0019-z PubMedCrossRef

27.

Norman RW, Bath SS, Robertson WG, Peacock M (1984) When should patients with symptomatic urinary stone disease be evaluated metabolically? J Urol 132(6):1137–1139PubMed

28.

Nayan M, Elkoushy MA, Andonian S (2012) Variations between two 24-h urine collections in patients presenting to a tertiary stone clinic. Can Urol Assoc J 6(1):30–33. doi:10.5489/cuaj.11131 PubMedCentralPubMed

29.

Parks JH, Goldfisher E, Asplin JR, Coe FL (2002) A single 24-h urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol 167(4):1607–1612PubMedCrossRef

30.

Pak CY, Peterson R, Poindexter JR (2001) Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol 165(2):378–381. doi:10.1097/00005392-200102000-00006 PubMedCrossRef

31.

Yagisawa T, Chandhoke PS, Fan J (1999) Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis. J Urol 161(5):1449–1452PubMedCrossRef

32.

Worcester EM, Coe FL (2010) Clinical practice. Calcium kidney stones. N Engl J Med 363(10):954–963. doi:10.1056/NEJMcp1001011 PubMedCentralPubMedCrossRef

33.

Daudon M, Lacour B, Jungers P (2005) High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant 20(2):468–469. doi:10.1093/ndt/gfh594 PubMedCrossRef

34.

Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY (2004) Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65(4):1422–1425. doi:10.1111/j.1523-1755.2004.00522.x PubMedCrossRef

35.

Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65(2):386–392. doi:10.1111/j.1523-1755.2004.00386.x PubMedCrossRef

36.

Hamm LL, Hering-Smith KS (2002) Pathophysiology of hypocitraturic nephrolithiasis. Endocrinol Metab Clin North Am 31(4):885–893, viii

37.

Curhan GC, Willett WC, Speizer FE, Stampfer MJ (2001) Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59(6):2290–2298. doi:10.1046/j.1523-1755.2001.00746.x PubMed

38.

Reddy ST, Wang CY, Sakhaee K, Brinkley L, Pak CY (2002) Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis 40(2):265–274. doi:10.1053/ajkd.2002.34504 PubMedCrossRef

39.

Pacifici R, Rothstein M, Rifas L, Lau KH, Baylink DJ, Avioli LV, Hruska K (1990) Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 71(1):138–145. doi:10.1210/jcem-71-1-138 PubMedCrossRef

40.

Yu TF (1978) Nephrolithiasis in patients with gout. Postgrad Med 63(5):164–170PubMed

41.

Pak CY, Adams-Huet B, Poindexter JR, Pearle MS, Peterson RD, Moe OW (2004) Rapid communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int 66(5):2032–2037. doi:10.1111/j.1523-1755.2004.00975.x PubMedCrossRef

42.

Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD (2002) Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur Urol 41(3):318–322PubMedCrossRef

43.

Pak CY (1991) Citrate and renal calculi: new insights and future directions. Am J Kidney Dis 17(4):420–425PubMedCrossRef

44.

Moe OW, Abate N, Sakhaee K (2002) Pathophysiology of uric acid nephrolithiasis. Endocrinol Metab Clin North Am 31(4):895–914PubMedCrossRef

45.

Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE (2004) Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int 66(2):777–785. doi:10.1111/j.1523-1755.2004.00803.x PubMedCrossRef

46.

Pak CY, Poindexter JR, Adams-Huet B, Pearle MS (2003) Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115(1):26–32PubMedCrossRef

47.

Pierratos AE, Khalaff H, Cheng PT, Psihramis K, Jewett MA (1994) Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dihydrate kidney stones. J Urol 151(3):571–574PubMed

48.

Daudon M, Reveillaud RJ (1984) Whewellite and weddellite: toward a different etiopathogenesis. The significance of morphological typing of calculi. Nephrologie 5(5):195–201PubMed

49.

Kuo RL, Lingeman JE, Evan AP, Paterson RF, Parks JH, Bledsoe SB, Munch LC, Coe FL (2003) Urine calcium and volume predict coverage of renal papilla by Randall’s plaque. Kidney Int 64(6):2150–2154. doi:10.1046/j.1523-1755.2003.00316.x PubMedCrossRef

50.

Moreira DM, Friedlander JI, Hartman C, Elsamra SE, Smith AD, Okeke Z (2013) Using 24-hour urinalysis to predict stone type. J Urol 190(6):2106–2111. doi:10.1016/j.juro.2013.05.115 PubMedCrossRef

51.

Torricelli FC, De S, Liu X, Calle J, Gebreselassie S, Monga M (2014) Can 24-hour urine stone risk profiles predict urinary stone composition? J Endourol 28(6):735–738. doi:10.1089/end.2013.0769 PubMedCrossRef

52.

Friedlander JI, Moreira DM, Hartman C, Elsamra SE, Smith AD, Okeke Z (2014) Age-related changes in 24-hour urine composition must be considered in the medical management of nephrolithiasis. J Endourol 28(7):871–876. doi:10.1089/end.2014.0002 PubMedCrossRef

Title: Metabolic evaluation of urinary lithiasis: what urologists should know and do
Authors: Julien Letendre
Jonathan Cloutier
Luca Villa
Luc Valiquette
Publication date: 01-02-2015
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 2/2015
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-014-1442-y

At a glance: The STEP trials

Springer Medicine

Metabolic evaluation of urinary lithiasis: what urologists should know and do

Abstract

Introduction

Materials and methods

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Materials and methods

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2015

CXCR4 is highly expressed at the tumor front but not in the center of prostate cancers

WJU special edition: surgical and medical management of stones

Diet: from food to stone

Urinary bladder mucosal responses to ischemia

Comparative pilot study of implantation techniques for pudendal neuromodulation: technical and clinical outcome in first 20 patients with chronic pelvic pain

Kidney stone analysis: “Give me your stone, I will tell you who you are!”